понеделник, 27 януари 2020 г.

Weekly Update: New diabetes clinical trial (8 items)

New diabetes clinical trial: The Effect of Lysulin on Glycemic Control and Advanced Glycation

Published on: January 20, 2020 at 07:00PM
Condition:   Type 2 Diabetes
Intervention:   Dietary Supplement: Lysulin
Sponsor:   Juraj Koska
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04234581?term=diabetes&sfpd_d=14 January 21, 2020 at 09:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Postprandial Metabolites of Meal Challenge Test in Diabetes State

Published on: January 20, 2020 at 07:00PM
Conditions:   Type2 Diabetes;   Postprandial Hyperglycemia
Interventions:   Behavioral: Strategies to lower postprandial hyperglycemia in T2D patients;   Behavioral: Control group
Sponsor:   Universiti Putra Malaysia
Enrolling by invitation
https://clinicaltrials.gov/ct2/show/NCT04234763?term=diabetes&sfpd_d=14 January 21, 2020 at 09:20PM

via ClinicalTrials.gov


New diabetes clinical trial: A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus

Published on: January 22, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04235959?term=diabetes&sfpd_d=14 January 22, 2020 at 05:20PM

via ClinicalTrials.gov


New diabetes clinical trial: PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients

Published on: January 22, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 1
Intervention:   Drug: Gan & Lee Insulin Glargine Injection
Sponsor:   Gan and Lee Pharmaceuticals, USA
Completed
https://clinicaltrials.gov/ct2/show/NCT04236895?term=diabetes&sfpd_d=14 January 22, 2020 at 05:20PM

via ClinicalTrials.gov


New diabetes clinical trial: ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes

Published on: January 22, 2020 at 07:00PM
Condition:   Type 1 Diabetes
Interventions:   Other: MDI;   Device: AHCL
Sponsor:   Medtronic Diabetes
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04235504?term=diabetes&sfpd_d=14 January 22, 2020 at 05:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Short Message Service for Type 2 Diabetes

Published on: January 22, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Behavioral: Mobile Phone Short Message Service
Sponsors:   Alexandria University;   High Institute of Public Health, Egypt
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04236206?term=diabetes&sfpd_d=14 January 22, 2020 at 05:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

Published on: January 23, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Metformin and Glimepiride (Low Dosage);   Drug: Metformin and Vildagliptin (Low Dosage);   Drug: Metformin and Insulin Glargine U100 (Low Dosage);   Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage);   Drug: Metformin and Glimepiride (Regular Dosage);   Drug: Metformin and Vildagliptin (Regular Dosage);   Drug: Metformin and Insulin Glargine U100 (Regular Dosage);   Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage)
Sponsor:   University of Jordan
Completed
https://clinicaltrials.gov/ct2/show/NCT04237493?term=diabetes&sfpd_d=14 January 23, 2020 at 03:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Community Health Workers in Pediatric Patients With Newly Diagnosed Type 1 Diabetes

Published on: January 23, 2020 at 07:00PM
Conditions:   Type 1 Diabetes;   Diabetes Mellitus;   Psychosocial Problem;   Compliance, Patient;   Health Behavior
Intervention:   Other: Community Health Worker added to diabetes team
Sponsors:   Children's Hospital of Philadelphia;   Leonard Davis Institute of Health Economics
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04238949?term=diabetes&sfpd_d=14 January 23, 2020 at 03:20PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар